Mast Therapeutics Provides Clinical Developments Update; Range-Bound Trading A Mid-Term Plausibility

By: via Benzinga
On Monday, Mast Therapeutics Inc (NYSE: MSTX) provided an update on its business strategy and the clinical development of its product ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.